Uveitis in a patient receiving rifabutin for Crohn's disease.
Awotesu
O
O
Barts & The London School of Medicine & Dentistry, London, UK.
Missotten
T
T
Pitcher
M C
MC
Lynn
W A
WA
Lightman
S
S
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D017291:Clarithromycin / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016927:Mycobacterium avium subsp. paratuberculosis; D010283:Paratuberculosis / Q000517:prevention & control; D017828:Rifabutin / Q000009:adverse effects*; D014392:Tuberculosis, Ocular / Q000517:prevention & control; D014606:Uveitis, Anterior / Q000139:chemically induced*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D017828:Rifabutin; D017291:Clarithromycin